Skip to content

Evaluation of the introduction of conservative oxygen therapy compared to normal oxygen therapy practice in patients undergoing cardiac surgery: A before and after audit

Evaluation of a change in PaO2/FiO2 ratio following the introduction of conservative oxygen therapy compared to normal oxygen therapy practice in patients undergoing cardiac surgery: A before and after audit

Status
Completed
Phases
Unknown
Study type
Observational
Source
ANZCTR
Registry ID
ACTRN12613001322729
Enrollment
546
Registered
2013-11-28
Start date
2015-03-27
Completion date
2015-04-27
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Cardiac surgical patients routinely receive supplemental oxygen immediately prior to, during and immediately following their cardiac surgical procedure. A major goal of anaesthetic care of the cardiac surgical patient is the maintenance of haemodynamic stability as well as the preservation of myocardial and systemic tissue oxygenation. Often cardiac surgical patients will receive supplemental oxygen and have supra-normal concentration of oxygen as a buffer of safety (Ihnken et al., 1998). However, cardiac surgical patients are particular susceptible to lung and myocardial injury attributable to hyperoxic states. Reactive oxygen species (ROS) are well known for their role in myocardial injury. ROS are free radicals (unpaired electrons) involved with oxidation-reduction reactions with other molecules. During cardiac surgery the formation of oxygen free radicals is accelerated from tissue injury and the use of cardiopulmonary bypass. Clinical studies have demonstrated apoptosis and deoxyribonucleic acid (DNA) fragmentation occurring after ischemia-reperfusion injury. In addition, prolonged high oxygen concentrations have been shown to decrease myocardial contractility and a decrease in heart rate which results in impaired cardiac function and may delay recovery (Joachimsson et al, 1996; Ihnken et al, 1998). The aim of this study is to evaluate the impact of a peri-operative change in oxygen therapy management for cardiac surgical patients based on emerging evidence. The change involved the adoption of a conservative oxygen therapy approach to oxygen therapy management during the perio-operative period. Conservatiive oxygen therapy is involves the deliberate manipulation of fraction of inspired oxygen (FiO2) concentration to achieve normal blood oxygen saturations. We plan to inlcude 100 cardiac surgical patients in the before period and 100 cardiac surgical patients in the after period.

Interventions

Conservative oxygen therapy involves the deliberate manipulation of fraction of inspired oxygen (FiO2) concentration to achieve normal blood oxygen saturations (pulse oximetry derived oxygen saturation 94-98%) during mechanical ventilation with an endotracheal tube. Data will be extracted from the medical records of 100 consecutive cardiac surigcal patients commencing in December 2013.

Sponsors

Austin Health
Lead SponsorHospital

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

Cardiac surgery

Exclusion criteria

- pregnancy - less than 18 years of age - receiving extra-corporeal membrane oxygenation (ECMO) - death expected within 24 hours

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026